arrow Log In to View Account     |      
HOME
Johns Hopkins Medicine
Hopkins Logo


 
NEOVASCULAR AMD: APPROACHES FOR IMPROVING VISUAL ACUITY AND REDUCING THE BURDEN OF CARE

Presented by the Johns Hopkins University School of Medicine.

This educational activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

GOAL

To provide retina specialists with up-to-date information on the use of vascular endothelial growth factor blockade for the treatment retinal diseases.

INTENDED AUDIENCE

This activity is designed for retina specialists. No prerequisites required.

LEARNING OBJECTIVE

After completing this activity, the participant will demonstrate the ability to:

  • Discuss how quality-of-life issues affect patients with age-related macular degeneration (AMD) to formulate treatment plans that will have a positive impact on these patients and their caregivers.
  • Recognize the role of doctor-patient communication in the management of AMD to better optimize treatment and improve patient outcomes.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

ACCREDITATION STATEMENT

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The estimated time to complete this educational activity: 1 hour.

Release date: October 1, 2011. Expiration date: October 1, 2013.

HOW TO CLAIM CREDIT

Please complete a brief pre-assessment before continuing with the monograph. After reading this monograph, participants may receive credit by completing the CME test and evaluation online, and receiving a score of 70% or higher.

Faculty
Full Disclosure Policy Affecting CME Activities:
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:

COURSE DIRECTOR
Quan Dong Nguyen, MD, MSc

Associate Professor of Ophthalmology
Retina Division
Diseases of the Retina and Vitreous, and Uveitis
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland

PARTICIPATING FACULTY
Diana V. Do, MD (Planner)

Associate Professor of Ophthalmology
Retina Division
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland

Peter K. Kaiser, MD
Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine
Cole Eye Institute
Cleveland, Ohio

Debra Gordon, MS
Medical Writer
Williamsburg, Virginia

Participating Faculty Disclosures
Dr Do reports serving as the principal investigator for research/grant support from Genentech, Inc, Heidelberg, and Regeneron Pharmaceuticals, Inc. Dr Do's spouse, Dr Nguyen, reports the below disclosures.

Dr Kaiser reports serving as a consultant for Alcon Laboratories, Bayer, Genentech, Inc, Novartis Pharmaceuticals Corporation, and Regeneron Pharmaceuticals, Inc.

Dr Nguyen reports receiving research/grant support from Abbott Laboratories, Genentech, Inc, Heidelberg Engineering, Lux Biosciences, Novartis Pharmaceuticals Corporation, Pfizer Inc, and Regeneron Pharmaceuticals, Inc; and serving as a consultant for Bausch & Lomb and Santen Pharmaceutical. Dr Nguyen's spouse, Dr Do, reports the above disclosures.

No other faculty members have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentation(s).

Planner Disclosures
Dr Do reports serving as the principal investigator for research/grant support from Genentech, Inc, Heidelberg, and Regeneron Pharmaceuticals, Inc. Dr Do's spouse, Dr Nguyen, reports the below disclosures.

Dr Nguyen reports receiving research/grant support from Abbott Laboratories, Genentech, Inc, Heidelberg Engineering, Lux Biosciences, Novartis Pharmaceuticals Corporation, Pfizer Inc, and Regeneron Pharmaceuticals, Inc; and serving as a consultant for Bausch & Lomb and Santen Pharmaceutical. Dr Nguyen's spouse, Dr Do, reports the above disclosures.

No other planners have indicated that they have any financial interests or relationships with a commercial entity.

Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution that receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).


Off-Label Product Discussion: The following faculty members have disclosed that their presentation will reference unlabeled/unapproved use of drugs or products:

Dr Do and Dr Kaiser: bevacizumab

DISCLAIMER
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
INTERNET CME POLICY
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based activity. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME activity. CME collects only the information necessary to provide you with the services that you request.
Confidentiality Disclaimer for CME Activity Participant
I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person's health or treatment that identifies the person. I also understand that while I am participating in this capacity I will be treated as a temporary member of Johns Hopkins for purposes of the Privacy Regulations only.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

“The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.”

For CME Questions, please contact the CME Office (410) 955-2959 or e-mail cmenet@jhmi.edu.


Johns Hopkins University School of Medicine
Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195
Reviewed & Approved by: General Counsel, Johns Hopkins Medicine (Updated 4/09)
HARDWARE & SOFTWARE REQUIREMENTS
Pentium 800 processor or greater, Windows 98/NT/200/XP or Mac OS 9/X or later, Microsoft Internet Explorer, Safari, Firefox, Windows Media Player 9.0 or later Flash player, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.
ACTIVITY
Instructions
The following activity consists of 3 sections: an unaccredited pre-test, a monograph, and a CME post-test and evaluation. All 3 sections must be completed to receive CME credit.

Pre-Test

Introduction
Neovascular AMD: Approaches for Improving Visual Acuity and Reducing the Burden of Care

Quan Dong Nguyen, MD, MSc, and Debra Gordon, MS

Review Article
Impact of AMD and Treatment Regimens on Patient-Reported Visual Function

Diana V. Do, MD, Debra Gordon, MS, and Peter K. Kaiser, MD

Patient/Clinician Interviews
Anti-VEGF Therapy and AMD: The Patient Perspective

Interview with Diana V. Do, MD, and Patient SF

Managing the Expectations of the Patient with AMD: Advice from a Patient and Physician
Interview with Peter K. Kaiser, MD, and Patient FG

Post-Test
procced to pretest
footer